sosei group corp
(4565:Tokyo Stock Exchange)
David Chiswell Ph.D.
|Age||Total Calculated Compensation||This person is connected to 41 board members in 4 different organizations across 6 different industries.|
See Board Relationships
Dr. David Chiswell, Ph.D., serves as Chairman and Interim Chief Executive Officer of Kymab Limited. Dr. Chiswell serves as Chairman of Albireo Pharma.He is an Advisor to a number of international private equity funds including BioComm in Melbourne, Australia. Dr. Chriswell was a Founder of Cambridge Antibody Technology, where he was responsible for operational management from 1990 to 2002, served as the Chief Executive Officer from 1996 to 2002. Dr. Chiswell has substantial ...
Kojimachi Tsuruya Hachiman BuildingPhone: 81 3 5210 3290
Tokyo, -- 102-0083
Fax: 81 3 5210 3291
Board Members Memberships*
Chairman of the Board
Chairman and Interim Chief Executive Officer
Education*There is no Education data available.
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|There is no Competitor Compensation data available.|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.